176 related articles for article (PubMed ID: 6464416)
1. A rare example of weakened expression of the Kell (K1) antigen.
Kline WE; Sullivan CM; Bowman RJ
Vox Sang; 1984; 47(2):170-3. PubMed ID: 6464416
[TBL] [Abstract][Full Text] [Related]
2. Unusual suppression of Kell system antigens in a healthy blood donor.
Norman PC; Daniels GL
Transfusion; 1988; 28(5):460-2. PubMed ID: 3420674
[TBL] [Abstract][Full Text] [Related]
3. The Kmod blood group phenotype in a healthy individual.
Winkler MM; Beattie KM; Cisco SL; Sigmund KE; Johnson CL; Rabin BI; Marsh WL
Transfusion; 1989 Sep; 29(7):642-5. PubMed ID: 2773032
[TBL] [Abstract][Full Text] [Related]
4. An individual with McLeod syndrome and the Kell blood group antigen K(K1).
Marsh WL; Schnipper EF; Johnson CL; Mueller KA; Schwartz SA
Transfusion; 1983; 23(4):336-8. PubMed ID: 6879675
[TBL] [Abstract][Full Text] [Related]
5. A new low-incidence antigen in the Kell blood group system: VLAN (KEL25).
Jongerius JM; Daniels GL; Overbeeke MA; Petty AC; Reid M; Oyen R; Rijksen H; van Leeuwen EF
Vox Sang; 1996; 71(1):43-7. PubMed ID: 8837356
[TBL] [Abstract][Full Text] [Related]
6. Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system.
Symmans WA; Shepherd CS; Marsh WL; Oyen R; Shohet SB; Linehan BJ
Br J Haematol; 1979 Aug; 42(4):575-83. PubMed ID: 476009
[TBL] [Abstract][Full Text] [Related]
7. K22, a 'new' para-Kell antigen of high frequency.
Bar Shany S; Ben Porath D; Levene C; Sela R; Daniels GL
Vox Sang; 1982 Feb; 42(2):87-90. PubMed ID: 7064432
[TBL] [Abstract][Full Text] [Related]
8. A novel variant of the human blood group K1 antigen.
Skradski K; Reid ME; Mount M; Polesky HF; Sausais L; Yacob M; Batts R
Vox Sang; 1994; 66(1):68-71. PubMed ID: 8146986
[TBL] [Abstract][Full Text] [Related]
9. Anti-Km in a transfused man with McLeod syndrome.
White W; Washington ED; Sabo BH; Stroup M; McCreary J; Oyen R; Marsh WL
Rev Fr Transfus Immunohematol; 1980; 23(3):305-17. PubMed ID: 7406997
[TBL] [Abstract][Full Text] [Related]
10. [Rare blood donors with irregular antibodies].
Milanović MK; Bujandrić N; Knezević NM
Med Pregl; 2013; 66(7-8):331-4. PubMed ID: 24069817
[TBL] [Abstract][Full Text] [Related]
11. A family with unusual Kell genotypes.
Walsh TJ; Daniels GL; Tippett P
Forensic Sci Int; 1981; 18(2):161-3. PubMed ID: 7297967
[No Abstract] [Full Text] [Related]
12. K23. A low-incidence antigen in the Kell blood group system identified by biochemical characterization.
Marsh WL; Redman CM; Kessler LA; DiNapoli J; Scarborough AL; Philipps AG; Mody KM
Transfusion; 1987; 27(1):36-40. PubMed ID: 3810821
[TBL] [Abstract][Full Text] [Related]
13. The Day phenotype: a "new" variant in the Kell blood group system.
Brown A; Berger R; Lasko D; Brokenshire D; Humphreys J; Stout T; Moore BP; Johnson CL; Mueller KA; Marsh WL
Rev Fr Transfus Immunohematol; 1982 Dec; 25(6):619-27. PubMed ID: 7170568
[No Abstract] [Full Text] [Related]
14. [Exclusion of paternity based on the Kell-cellano blood group system and family pedigree studies].
Hölgyéné VZ; Szabó A
Morphol Igazsagugyi Orv Sz; 1986 Oct; 26(4):288-90. PubMed ID: 3785246
[No Abstract] [Full Text] [Related]
15. Transfusion support for a patient with McLeod phenotype without chronic granulomatous disease and with antibodies to Kx and Km.
Bansal I; Jeon HR; Hui SR; Calhoun BW; Manning DW; Kelly TJ; Lee S; Baron BW
Vox Sang; 2008 Apr; 94(3):216-220. PubMed ID: 18167163
[TBL] [Abstract][Full Text] [Related]
16. Identification of a defect in the intracellular trafficking of a Kell blood group variant.
Yazdanbakhsh K; Lee S; Yu Q; Reid ME
Blood; 1999 Jul; 94(1):310-8. PubMed ID: 10381527
[TBL] [Abstract][Full Text] [Related]
17. Isolation of Kell-active protein from the red cell membrane.
Redman CM; Marsh WL; Mueller KA; Avellino GP; Johnson CL
Transfusion; 1984; 24(2):176-8. PubMed ID: 6200970
[TBL] [Abstract][Full Text] [Related]
18. A novel KEL*1,3 allele with weak Kell antigen expression confirming the cis-modifier effect of KEL3.
Körmöczi GF; Scharberg EA; Gassner C
Transfusion; 2009 Apr; 49(4):733-9. PubMed ID: 19347978
[TBL] [Abstract][Full Text] [Related]
19. [Fetal erythroblastosis in Kell incompatibility].
Fuith LC; Bichler A; Schönitzer D
Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):131-3. PubMed ID: 3471624
[TBL] [Abstract][Full Text] [Related]
20. Haematological changes associated with the McLeod phenotype of the Kell blood group system.
Wimer BM; Marsh WL; Taswell HF; Galey WR
Br J Haematol; 1977 Jun; 36(2):219-24. PubMed ID: 871435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
